Similar articles

• Anti-tumour necrosis factor-alpha therapy in heart failure: future directions.

  Balakumar P, Singh M. Balakumar P, et al. Basic Clin Pharmacol Toxicol. 2006 Dec;99(6):391-7. doi: 10.1111/j.1742-7843.2006.pto_508.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 17169118 Review.
• Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.

  Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P. Cohen JD, et al. J Rheumatol. 2007 Feb;34(2):380-5. Epub 2006 Oct 1. J Rheumatol. 2007. PMID: 17013997
• Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.

  Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, Kita M, Kitas GD. Metsios GS, et al. Rheumatology (Oxford). 2007 Dec;46(12):1824-7. doi: 10.1093/rheumatology/kem291. Rheumatology (Oxford). 2007. PMID: 18032540
• Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.

  Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, Triolo G, Valentini G, Valesini G; GISEA Group. Ferri C, et al. J Rheumatol. 2008 Oct;35(10):1944-9. Epub 2008 Aug 1. J Rheumatol. 2008. PMID: 18688917
• Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.

  Skomsvoll JF, Wallenius M, Koksvik HS, Rødevand E, Salvesen KA, Spigset O, Kvien TK. Skomsvoll JF, et al. Nat Clin Pract Rheumatol. 2007 Mar;3(3):156-64. doi: 10.1038/ncprheum0426. Nat Clin Pract Rheumatol. 2007. PMID: 17334338 Review.